A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infection
Cell Reports Medicine, January 2, 2026
Cell Reports Medicine, January 2, 2026
Completed study Official Study Title Bezlotoxumab Υielded Οutcomes by addressing personalized Needs in Clostridioides Difficile infection: the BEYOND double-blind randomized clinical trial Brief Description Previous data from our group have shown that integrated information from SNPs of the host DNA, IL-8 and the enrichment of the stool microbiome can indicate the patients with infection